Stocks
Iovance Biotherapeutics (IOVA) EV/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -16.6 | -23.3 | -7.32 | -1.68 | -4.00 | -2.17 | ||
| Changes by years, y/y, % | +443% | +40% | -69% | -77% | +138% | +5.5% | |||
Iovance Biotherapeutics. EV/EBITDA
Iovance Biotherapeutics. EV/EBITDA, changes, %
Iovance Biotherapeutics (IOVA) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | -1.93 | -4.32 | -8.51 | -4.74 | -6.38 | -2.17 | |
| Changes by years, y/y, % | -42% | +152% | +361% | +44% | +231% | |||
| Changes by quarters, q/q, % | -41% | +124% | +97% | -44% | +35% | |||
